Beware.
Kazia still linked to Novogen founder who now runs Noxopharm...DYOR
Sydney, 19 March 2019 – Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an arrangement to sell the remainder of its holding in the ordinary shares of Noxopharm Limited via a single block trade. Kazia expects the transaction to yield proceeds of approximately $2.1m, bringing the total gross proceeds from sale of our holding to approximately $2.4m. The proceeds of the transaction will be applied to Kazia’s own R&D programs, each of which will be yielding important data read-outs in Q2 calendar 2019. Kazia retains 3 million unlisted options in Noxopharm, with an exercise price of $0.80
Former Novogen ($NVGN) CEO Graham Kelly is raising money for a new Australian biotech called Noxopharm that is said to be ready with a Phase I oncology candidate, NOX66 (idronoxil), for later this year that also follows a path of a drug touted by his former firm to overcome chemotherapy resistance.Kelly hopes to get up and running with AU$6 million via an initial public offering on the Australian Stock Exchange (ASX) of 30 million shares at $0.20 each, the company said in a statement."NOX66 is an innovative dosage form of the drug candidate, idronoxil. Idronoxil overturns drug-resistance mechanisms, but has failed in clinical studies to reproduce the potency observed in the laboratory," the company said in the release.
- Forums
- ASX - By Stock
- PTX
- Four ASX cancer stocks to watch...NAB Trade
Four ASX cancer stocks to watch...NAB Trade, page-12
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
-0.001(2.33%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.2¢ | $8.214K | 193.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32561 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 5169 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32561 | 0.042 |
1 | 490222 | 0.041 |
9 | 797493 | 0.040 |
6 | 539000 | 0.039 |
3 | 375000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 5169 | 1 |
0.044 | 225514 | 2 |
0.045 | 845136 | 7 |
0.047 | 525000 | 2 |
0.048 | 308027 | 2 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online